| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 11,967 | 12,602 | 12,449 | 12,156 | | Cost of Revenue | 3,036 | 3,444 | 3,721 | 4,099 | | | Gross Profit |
-
| 9,158 | 8,728 | 8,057 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 3,444 | 4,216 | 3,579 | 3,365 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 2,709 | 2,688 | 6,998 | 6,177 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| 2,254 | (1,849) | (1,485) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 2,778 | 2,254 | (1,849) | (1,485) | | Interest Expense | 1,212 | 1,372 | 1,449 | 1,524 | | Income Before Tax | 1,566 | 882 | (3,298) | (3,009) | | Income Tax Expense | 71 | 197 | (720) | (1,666) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,234 | 685 | (2,578) | (1,343) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,495 | 685 | (2,578) | (1,343) | | Preferred Stock And Other Adjustments | (251) | (251) | (250) | (109) | | | Net Income Applicable To Common Shares | $1,244 | $434 | ($2,828) | ($1,452) |
|
0.51% Nasdaq 
Income Statement
